MedPath

Evaluating the role of Positron Emission Tomography (PET) scanning as a non invasive technique to diagnose graft vs host disease of the gastrointestinal tract following bone marrow transplantation.

Not Applicable
Conditions
Graft vs Host Disease of the Gastrointestinal tract following bone marrow transplant.
Blood - Haematological diseases
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Cancer - Leukaemia - Acute leukaemia
Registration Number
ACTRN12612001053819
Lead Sponsor
Alfred Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
60
Inclusion Criteria

Clinical Suspicion of acute Graft vs Host disease of the gastrointestinal tract Day 20-180 post allogeneic bone marrow transplantation

Exclusion Criteria

Commencement of therapy for suspected acute graft vs host disease of the gastrointestinal tract prior to PET scanning

Significant uncontrolled intercurrent illness

Lactating or pregnant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess whether PET scanning accurately detects acute graft vs host disease of the gastrointestinal tract when clinically suspected.[PET scan - At time graft vs host disease is clinically suspected<br>Gastroscopy and Colonoscopy - Within 7 days of PET scan]
Secondary Outcome Measures
NameTimeMethod
A[NA]
© Copyright 2025. All Rights Reserved by MedPath